Edap (EDAP +3.4%) gains after saying the FDA has given the thumbs-up on a pre-market approval...

|About: EDAP TMS S.A. (EDAP)|By:, SA News Editor

Edap (EDAP +3.4%) gains after saying the FDA has given the thumbs-up on a pre-market approval application for its Ablatherm Integrated Imaging HIFU device, a high-intensity utrasound treatment for low-risk, localized prostate cancer.